LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $51.00 price target on the stock.
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors [Yahoo! Finance]
VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight [Yahoo! Finance]
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its price target raised by analysts at Citigroup Inc. from $44.00 to $47.00. They now have a "buy" rating on the stock.
Form 8-K LENZ Therapeutics, Inc. For: Apr 15
Form EFFECT LENZ Therapeutics, Inc.
Form EFFECT LENZ Therapeutics, Inc.
Form 424B5 LENZ Therapeutics, Inc.
Form 424B3 LENZ Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.